Dual blockade of endothelin action exacerbates up-regulated VEGF angiogenic signaling in the heart of lipopolysaccharide-induced endotoxemic rat model

• Published in: Life sciences (1973) Vol. 118; no. 2; pp. 364 - 369
• Main Authors: Oki, Masami, Jesmin, Subrina, Islam, Md. Majedul, Mowa, Chishimba Nathan, Khatun, Tanzila, Shimojo, Nobutake, Sakuramoto, Hideaki, Kamiyama, Junko, Kawano, Satoru, Miyauchi, Takashi, Mizutani, Taro
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 24.11.2014
• Subjects: Animals; Blood Gas Analysis; Disease Models, Animal; Endothelin receptor antagonist (SB-209670); Endothelin Receptor Antagonists - pharmacology; Endothelin Receptor Antagonists - therapeutic use; Endothelin-1 - blood; Endotoxemia - blood; Endotoxemia - metabolism; Endotoxemia - physiopathology; Endotoxemic heart; Hemodynamics - drug effects; Lipopolysaccharide; Lipopolysaccharides; Male; Myocardium - metabolism; Myocardium - pathology; Neovascularization, Physiologic - drug effects; Nitric Oxide - metabolism; Nitric Oxide Synthase Type III - metabolism; Rats, Wistar; Signal Transduction - drug effects; Tumor Necrosis Factor-alpha - blood; Up-Regulation - drug effects; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - blood; Vascular Endothelial Growth Factor A - metabolism; Lipopolysaccharide; Endotoxemic heart; Vascular endothelial growth factor; Endothelin receptor antagonist (SB-209670)
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2014.02.008

Sepsis is a cluster of heterogeneous syndromes associated with progressive endotoxemic developments, ultimately leading to damage of multiple organs, including the heart. However, the pathogenesis of sepsis-induced myocardial dysfunction is still not fully understood. The present study is the first to examine alterations in expression of key angiogenic signaling system mediated by vascular endothelial growth factor (VEGF) in septic heart and the effects of endothelin dual blocker (ETDB) on it. Normal Wistar rats were either administered with: a) vehicle only (control group), b) lipopolysaccharide only (LPS: 15mg/kg) and then sacrificed at different time points (1h, 3h, 6h and 10h), and c) the last group was co-administered with LPS and ETDB (SB-209670, 1mg/kg body weight) for 6h and then sacrificed. Administration of LPS resulted in increases in levels of: a) serum tumor necrosis factor (TNF)-α, b) serum VEGF and c) serum endothelin (ET)-1 levels accompanied by up-regulation of cardiac VEGF and its downstream angiogenic signaling molecules. While cardiac TNF-α level was unchanged among experimental groups, cardiac ET-1 level was significantly higher in LPS-administered group. We conclude that elevation in VEGF angiogenic signaling may be triggered by diminished oxygenation in the myocardium following LPS administration as a consequence of sepsis-induced microvascular dysfunction. Because of this cardiac dysfunction, oxygen supply may be inadequate at microregional level to support the normal heart metabolism and function. ETDB at 6h further increased the elevated levels of VEGF angiogenic signaling in endotoxemic heart. [Display omitted]